Related Experiment Video
Updated: May 13, 2026

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using Poly(I:C) to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Does Systemic Inflammation Play a Role in Pediatric Psychosis?
First-episode psychosis in youth is linked to systemic inflammation and blood-brain barrier disruption. Elevated inflammatory markers and S100B levels were observed in pediatric patients with new-onset psychosis.
Area of Science:
- Neuroscience
- Psychiatry
- Immunology
Background:
- Emerging evidence suggests inflammation plays a role in neuropsychiatric disorders like schizophrenia.
- Previous research primarily focused on adult populations, leaving a gap in understanding pediatric cases.
Purpose of the Study:
- To investigate the association between inflammation and first-episode psychosis in children.
- To test the hypothesis that early-stage psychosis in youth involves inflammatory processes.
Main Methods:
- Studied pediatric patients with new-onset psychosis (n=80) and matched healthy controls (n=66).
- Measured serum levels of cytokines and S100B, a marker of blood-brain barrier damage.
- Compared hematologic values and inflammatory mediators between psychosis patients and controls.
Main Results:
- Patients with first-episode psychosis showed significantly higher absolute monocyte and lymphocyte counts.
- Elevated serum levels of S100B indicated blood-brain barrier disruption in pediatric psychosis.
- Increased levels of multiple inflammatory mediators, including TNF-α, IL-1β, IL-6, IL-5, IL-10, and IFN-γ, were found in children with psychosis.
Conclusions:
- Findings support a strong connection between systemic inflammation, blood-brain barrier damage, and first-episode psychosis in pediatric patients.
- Highlights the potential role of inflammatory pathways in the early development of psychosis in youth.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychosis and Antipsychotic Drugs: Overview
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Acute Inflammation II: Local and Systemic Effects